Sabra Health Care REIT, Inc.
SBRANasdaq
$20.11
↓ -0.2%Jul 17 close · end-of-day
Price
1Y↑ +17.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$5.1B
Enterprise Value
$7.7B
P/E
31.9
P/S
6.3
P/B
1.8
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
6.0%
Revenue (TTM)
$812.8M
Net Income (TTM)
$156.2M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
19.2%
ROE
5.6%
ROIC
—
Debt / Equity
1.0
Net Cash
-$2.5B
Return 1Y
+18.3%
Company profile
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment. The company's real estate portfolio included 287 Skilled Nursing/Transitional Care facilities, 64 Senior Housing communities (ÂSenior Housing - LeasedÂ) and 27 Specialty Hospitals and Other facilities.
- CEO
- Richard K. Matros
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Trading
- Employees
- 40
- Headquarters
- California
- Website
- sabrahealth.com
Management & directors
- Costa Michael LourencoExecutive VP, CFO & Treasurer
- Flores JessicaExecutive VP & CAO
- Matros Richard KChair, CEO and President
- Smith DarrinExecutive VP, CIO & Secretary
- Nevo-Hacohen TalyaExecutive VP, CIO & Treasurer
Roles derived from SEC Form 4 filings.
Earnings
SBRA Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$221.8M↑ +20.8%
Diluted EPS$0.16↓ -5.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $598.6M | $569.5M | $624.8M | $647.5M | $703.2M | $774.6M |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | $138.4M | -$113.3M | -$77.6M | $13.8M | $126.7M | $155.6M |
| Diluted EPS | $0.67 | -$0.52 | -$0.34 | $0.06 | $0.54 | $0.64 |
| Operating cash flow | $354.9M | $356.4M | $315.7M | $300.6M | $310.5M | $348.6M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | 23.1% | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $176.1M | $178.0M | $182.3M | $183.5M | $189.2M | $190.0M | $211.9M | $221.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $24.0M | $29.8M | $46.7M | $40.3M | $65.5M | $22.5M | $27.2M | $40.9M |
| Diluted EPS | $0.10 | $0.13 | $0.20 | $0.17 | $0.27 | $0.09 | $0.11 | $0.16 |
| Operating cash flow | $80.1M | $97.7M | $80.0M | $80.3M | $81.0M | $100.0M | $87.4M | $98.4M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | 13.6% | 16.7% | 25.6% | 22.0% | 34.7% | 11.9% | 12.8% | 18.4% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-17 | Malehorn Jeffrey A. | Award | 8,310 | $0.00 | $0.00 | filing |
| 2026-06-17 | Kono Ann | Award | 8,310 | $0.00 | $0.00 | filing |
| 2026-06-17 | KATZMANN LYNNE S | Award | 8,310 | $0.00 | $0.00 | filing |
| 2026-06-17 | FOSTER MICHAEL J | Award | 8,310 | $0.00 | $0.00 | filing |
| 2026-06-17 | Cusack Catherine | Award | 8,310 | $0.00 | $0.00 | filing |
| 2026-06-17 | Barbarosh Craig A. | Award | 8,310 | $0.00 | $0.00 | filing |
| 2026-05-29 | Malehorn Jeffrey A. | Award | 817 | $0.00 | $0.00 | filing |
| 2026-05-29 | Kono Ann | Award | 817 | $0.00 | $0.00 | filing |
| 2026-05-29 | KATZMANN LYNNE S | Award | 817 | $0.00 | $0.00 | filing |
| 2026-05-29 | FOSTER MICHAEL J | Award | 817 | $0.00 | $0.00 | filing |
| 2026-05-29 | FOSTER MICHAEL J | Gift | 500 | $0.00 | $0.00 | filing |
| 2026-05-29 | Cusack Catherine | Award | 817 | $0.00 | $0.00 | filing |
| 2026-05-29 | Barbarosh Craig A. | Award | 817 | $0.00 | $0.00 | filing |
| 2026-05-29 | FLORES JESSICA· Executive VP & CAO | Award | 385 | $0.00 | $0.00 | filing |
| 2026-05-29 | Smith Darrin· Executive VP, CIO & Secretary | Award | 501 | $0.00 | $0.00 | filing |
| 2026-05-29 | Costa Michael Lourenco· Executive VP, CFO & Treasurer | Award | 4,200 | $0.00 | $0.00 | filing |
| 2026-05-29 | MATROS RICHARD K· Chair, CEO and President | Award | 14,003 | $0.00 | $0.00 | filing |
| 2026-05-27 | FOSTER MICHAEL J | Gift | 490 | $0.00 | $0.00 | filing |
| 2026-05-22 | FOSTER MICHAEL J | Gift | 813 | $0.00 | $0.00 | filing |
| 2026-03-25 | FLORES JESSICA· Executive VP & CAO | Sale | 15,231 | $19.86 | $302,487.66 | filing |
| 2026-02-27 | Malehorn Jeffrey A. | Award | 781 | $0.00 | $0.00 | filing |
| 2026-02-27 | Kono Ann | Award | 781 | $0.00 | $0.00 | filing |
| 2026-02-27 | KATZMANN LYNNE S | Award | 781 | $0.00 | $0.00 | filing |
| 2026-02-27 | FOSTER MICHAEL J | Award | 781 | $0.00 | $0.00 | filing |
| 2026-02-27 | Cusack Catherine | Award | 781 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.